Login to Your Account



VCs debate post-Brexit future for biopharma ecosystem in U.K.

By Nuala Moran
Staff Writer

Wednesday, February 8, 2017

LONDON – One of Europe's leading biotech venture capital investors has warned the U.K. could see its top science assets moved offshore for commercialization once the country leaves the EU.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription